Amarnath Sharma
Affiliations: | 1980-1994 | Pharmaceutical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Google:
"Amarnath Sharma"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chandra R, Liu P, Breen JD, et al. (2007) Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Clinical Pharmacokinetics. 46: 247-59 |
| Pitot HC, Adjei AA, Reid JM, et al. (2006) A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 58: 165-72 |
| Zhou Q, Olivo M, Lye KYK, et al. (2005) Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models Cancer Chemotherapy and Pharmacology. 56: 569-577 |
| Chow FS, Sharma A, Jusko WJ. (2001) Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. Journal of Pharmacokinetics and Biopharmaceutics. 27: 559-75 |
| Egan TD, Sharma A, Ashburn MA, et al. (2000) Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers. Anesthesiology. 92: 665-73 |
| Sharma A, Goldberg MJ, Cerimele BJ. (2000) Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. The Journal of Clinical Pharmacology. 40: 161-167 |
| Sharma A, Jusko WJ, Fulmor IE, et al. (1999) Pharmacokinetics and pharmacodynamics of avitriptan during intravenous administration in healthy subjects. Journal of Clinical Pharmacology. 39: 685-94 |
| Sharma A, Slugg PH, Hammett JL, et al. (1999) Estimation of oral bioavailability of a long half-life drug in healthy subjects. Pharmaceutical Research. 15: 1782-6 |
| Sharma A. (1998) Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena Journal of Pharmaceutical Sciences. 87: 1577-1584 |
| Sharma A, Slugg PH, Hammett JL, et al. (1998) Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteers. The Journal of Clinical Pharmacology. 38: 1116-1121 |